Logo

Luminex Q4 Revenues Rise 8.3 Percent, Net Loss Balloons 71 Percent

Feb 10, 2005

NEW YORK, Feb. 10 (GenomeWeb News) - Luminex yesterday reported that fourth-quarter revenue increased 8.3 percent to $9.1 million from $8.4 million in the year-ago quarter.

 

R&D spending for the three months ended Dec. 31, 2004, increased 13 percent to $908,000 from $807,000 for the same quarter in 2003.

 

Net loss in the current quarter surged 71 percent to $1.1 million from $643,000 in the year-ago quarter.

 

The company had $36 million in cash and cash equivalents on hand as of Dec. 31.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.